Tweets
Baseline predictors of D2TRA in naive recent onset RA 1000pts
-female sex
-higher joint count
-erosions
-pulmonary involvement
-depression
-fatigue
#EULAR24 AbstOP0118 @RheumNow
Aurelie Najm @AurelieRheumo ( View Tweet )
1 year 11 months ago
COMPARATIVE SAFETY OF JAK INHIBITORS VERSUS TNF OR IL-17 INHIBITORS FOR CARDIOVASCULAR DISEASE, VENOUS THROMBOEMBOLISM AND CANCER IN PSORIATIC ARTHRITIS AND AXIAL - no signal of significant difference but channeling bias last few years @RheumNow #EULAR2024
Peter Nash @drpnash ( View Tweet )
1 year 11 months ago
COMPARATIVE RISK OF MORTALITY IN NEW USERS OF PRESCRIPTION OPIOIDS FOR NON-CANCER PAIN: RESULTS FROM THE INTERNATIONAL PHARMACOSURVEILLANCE STUDY - HR 9-13 increased deaths narcotic use compared with codeine UK Boston Montreal >1 million pts included @RheumNow #EULAR2024
Peter Nash @drpnash ( View Tweet )
1 year 11 months ago
3 pain clusters in AxSpA - tres intéressant @RheumNow #EULAR2024 https://t.co/ZgXvsxHlJu
Peter Nash @drpnash ( View Tweet )
1 year 11 months ago
OP0202 looks at phenotypes of #RAILD in a cluster analysis
🌎Large multinational cohort
2⃣Two key clusters identified
📈Male sex, older age at RA & ILD onset, European ethnicity, smoking and CCP & RF positivity more frequent in cluster 1 vs 2
@RheumNow #EULAR2024 @Juge_P_A
Mrinalini Dey @DrMiniDey ( View Tweet )
1 year 11 months ago
RheumNow’s expanded coverage of the #EULAR2024 annual meeting is sponsored in part by Bristol Myers Squibb and UCB. All content is chosen by RheumNow & our Faculty
Dr. John Cush @RheumNow ( View Tweet )
1 year 11 months ago
GOLMePsA RCT early naive PsA
Golimumab or PBO in addition to MTX+IM GCs
No difference wk52
ACR20 GOL 76% PBO 55%
MDA GOL 55% PBO 41%
PBO arm received higher GC dose
No new safety signal
@RheumNow AbstOP0148 #EULAR2024 https://t.co/bj7YNXhssm
Aurelie Najm @AurelieRheumo ( View Tweet )
1 year 11 months ago
📺 Join @RheumNow, @Yuz6Yusof & I for the Daily Recap over on @YouTube
⏩ https://t.co/D3HZGUdi9t
⏰ TODAY 18:00 CEST
👋 See you there!
#EULAR2024
Mrinalini Dey @DrMiniDey ( View Tweet )
1 year 11 months ago
Nationwide epi study of lymphoproliferative disorders in Sjogren's. All pts in France!
4 % prevalence
More in males and those with cryos and MGUS
#EULAR2024
@rheumnow
abst#OP0207 https://t.co/bEaWpTD7x3
Links:
Bella Mehta @bella_mehta ( View Tweet )
1 year 10 months ago
Severe refractory Sjogrens - not in RCTs but some meds such as CD20 - Obinutuzumab, CART have been reported.
A summary of slides @RheumNow https://t.co/9HQRAj3rzt
Links:
Bella Mehta @bella_mehta ( View Tweet )
1 year 11 months ago
CD40 and CD40L (CD154) inhibition
CD-40 monoclonal antibody
CD 40 Ligand blockade- Dazodalibep
@RheumNow https://t.co/n9CcrujVwa
Links:
Bella Mehta @bella_mehta ( View Tweet )
1 year 11 months ago
#EULAR2024 POS0237 RNA-seq of muscle biopsy in inflammatory myopathy (IIM) showed distinct gene expressions underlying muscle damage between DM, Antisynthetase & PM. Potential targets for future therapeutics @RheumNow @IzukaShinji https://t.co/nf0pp2RhaE
Links:
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
1 year 11 months ago
